共 44 条
- [31] 5ASA blocks proliferation and expression of Wnt/beta-catenin target genes in epithelial cells after T cell activation.[J]. GASTROENTEROLOGY, 2005, 128 (04) : A197 - A197Manjali, JJDirisina, RTang, YMGrimm, GRJamal, YBarrett, TA
- [32] Wnt/beta-catenin signaling activates dUTP pyrophosphatase, a regulator of cellular dUTP levels, to prevent uracil misincorporation into DNA in human liver cancer stem cells[J]. HEPATOLOGY, 2015, 62 : 554A - 554AAsahina, YoshiroYamashita, TaroTakatori, HajimeOishi, NaokiNio, KoukiHayashi, TakehiroNomura, YoshimotoHayashi, TomoyukiYoshida, MarikoHashiba, TomomiSuda, TsuyoshiHonda, MasaoKaneko, Shuichi
- [33] Inhibition of Notch signaling causes progenitor-to-hepatocyte differentiation and regressions in a subset of hepatocellular carcinoma by controlling C/EBPα expression and HNF4α activity[J]. CANCER RESEARCH, 2022, 82 (12)Seidel, KerstinPiskol, RobertThi Thu Thao NguyenCottonham, CharisaMerchant, MarkSiebel, Christian
- [34] DACH1, associated with a good prognosis and sensitivity to sorafenib in hepatocellular carcinoma, inhibits Wnt/beta-catenin signaling by suppressing the EGFR/ERK/FOXM1 axis[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 52 - 53Hu, LingWang, DongxuZhu, HongbinMa, LongtengHu, ShipingZhao, XiangyangRen, ShuyaoZhan, SujuanHe, YuzhuoLi, Jiana
- [35] miR-22 promotes stem cell traits via activating Wnt/beta-catenin signaling in cutaneous squamous cell carcinoma (vol 40, pg 5799, 2021)[J]. ONCOGENE, 2022, 41 (11) : 1674 - 1676Yuan, ShukaiZhang, PeitaoWen, LiqiJia, ShikaiWu, YufanZhang, ZhenleiGuan, LizhaoYu, ZhengquanZhao, Li
- [36] Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes[J]. JOURNAL OF PATHOLOGY, 2003, 201 (02): : 250 - 259Prange, WBreuhahn, KFischer, FZilkens, CPietsch, TPetmecky, KEilers, RDienes, HPSchirmacher, P
- [37] Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation[J]. CANCER BIOLOGY & THERAPY, 2016, 17 (05) : 558 - 565Wu, NingZhang, Yu-LingWang, Hai-TianLi, Da-WeiDai, Hui-JuanZhang, Qi-QiZhang, JiangMa, YongXia, QiangBian, Jian-MinHang, Hua-Lian
- [38] FHL2 Mediates Dexamethasone-Induced Mesenchymal Stem Cell Osteogenic Differentiation by Activating Wnt/beta-Catenin Signaling and Runx2 Expression.[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S385 - S385Hamidouche, Z.Hay, E.Vaudin, P.Charbord, P.Marie, P. J.Fromigue, O.
- [39] Wnt/beta-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma by increasing hif-1alpha activity and decreasing hypoxia-associated cell death[J]. HEPATOLOGY, 2012, 56 : 614A - 614AZhang, QiBai, XueliMa, TaoChen, WeiLiu, HaoHu, QidaLiang, ChaoXia, XuefengYu, XiazhenZhi, XiaoLiang, Tingbo
- [40] Effect of human umbilical cord blood derived CD34+ hematopoietic stem cell on the expression of Wnt4 and P53 genes in a rat model of hepatocellular carcinoma[J]. TISSUE & CELL, 2018, 50 : 125 - 132Sherif, Rania NaiemAbdellatif, HusseinHazem, NohaEbrahim, Neven A.Saleh, DaliaShiha, GamalEltahry, HudaBotros, Kamal G.Gabr, Omar M.